Vimarsana
Biggest News Aggregation in the World

Page 7 - Genevant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genevant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genevant Sciences Today - Breaking & Trending Today

Moderna fends off Arbutus appeal in COVID vaccine patent fight - Vimarsana News

Moderna fends off Arbutus appeal in COVID vaccine patent fight

The Federal Circuit's decision does not affect an ongoing lawsuit filed by Arbutus and Genevant Sciences - a joint venture between Arbutus and Roivant Sciences Ltd - against Moderna last year in...

Moderna Fends Off Arbutus Appeal in COVID-19 Vaccine Patent Fight - Vimarsana News

Moderna Fends Off Arbutus Appeal in COVID-19 Vaccine Patent Fight

A US appeals court handed Moderna a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma patent related to the companies' legal fight over Moderna's blockbuster COVID-19 vaccines.

Moderna fends off Arbutus appeal in COVID-19 vaccine patent fight - Vimarsana News

Moderna fends off Arbutus appeal in COVID-19 vaccine patent fight

A U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp patent related to the companies' legal fight over Moderna's blockbuster COVID-19... | April 11, 2023

Moderna fends off Arbutus appeal in COVID-19 vaccine patent fight - Vimarsana News

Moderna fends off Arbutus appeal in COVID-19 vaccine patent fight

A U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp patent related to the companies' legal fight over Moderna's blockbuster COVID-19 vaccines.

Moderna fends off Arbutus appeal in COVID-19 vaccine patent fight - Vimarsana News

Moderna fends off Arbutus appeal in COVID-19 vaccine patent fight

By Blake Brittain (Reuters) -A U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp patent ...